Form 4: Beta Bionics CMO Executes Tax-Related Stock Sale

Chief Medical Officer Steven Jon Russell sold 4,222 shares of Beta Bionics common stock to satisfy tax withholding obligations.

Summary

• Steven Jon Russell, Chief Medical Officer of Beta Bionics, Inc., sold 4,222 shares of common stock on June 2, 2026.
• The shares were sold at a weighted average price of $12.6071 per share, with individual transaction prices ranging from $12.30 to $12.93.
• The sale was conducted to cover tax withholding obligations related to the vesting of restricted stock units.
• Following this transaction, the reporting person retains beneficial ownership of 173,849 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale is purely administrative and related to tax obligations rather than a strategic shift in ownership.

Positives

• The transaction was a routine sale to cover tax obligations rather than a discretionary divestment of holdings.

Negatives

• The sale reduces the insider's direct equity stake in the company.

Risks

• None identified; this is a standard administrative transaction.

Future Outlook

No forward-looking guidance or strategic outlook provided in this filing.

Management Comments

• The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

Industry Context

StockSavvy.ai notes that routine insider sales to cover tax obligations upon the vesting of equity awards are standard corporate practice and generally do not signal a change in management's confidence in the company's long-term prospects.

Comparison to Industry Standards

• The transaction aligns with standard executive compensation and tax compliance practices observed across the medical device and biotechnology sectors.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was for tax compliance purposes.

Next Steps

• None mentioned.

Key Dates

Keywords

Beta Bionics, BBNX, Insider Trading, Form 4, Chief Medical Officer, Equity Vesting